NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution

Autor: Biau, J., Durando, X., Boux, F., Molnar, I., Moreau, J., Leyrat, B., Guillemin, F., Lavielle, A., Cremillieux, Y., Seddik, K., Dufort, S., De Beaumont, O., Thivat, E., Le Duc, G.
Zdroj: In Clinical and Translational Radiation Oncology September 2024 48
Databáze: ScienceDirect